BRAF and NRAS prognostic values in conjunctival melanoma: analysis and literature review.

Francisco Javier Valentín-BravoÁlvaro Pérez-RodríguezCiro García-ÁlvarezElena García-LagartoMaría Antonia Saornil-Álvarez

Published in: Arquivos brasileiros de oftalmologia (2022)

BRAF and NRAS mutations may be risk factors for recurrence and shorter survival in conjunctival melanoma, which would make these patients candidates for targeted therapies and comprehensive and individualized follow-up. All these data warrant standardized prospective studies.

Keyphrases

wild type
end stage renal disease
newly diagnosed
ejection fraction
peritoneal dialysis
electronic health record
skin cancer
metastatic colorectal cancer
artificial intelligence
case control
basal cell carcinoma